ROR1 and lung adenocarcinoma: Additionally, among lung adenocarcinoma patients with stage I and II (n = 29), 41% (12/29) had weak or focal expression, 14% (4/29) had moderate expression, and 14% (4/29) had strong ROR1 expression.